Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets: 2011-2025

Historic Prepaid Assets for Niagen Bioscience (NAGE) over the last 12 years, with Sep 2025 value amounting to $2.0 million.

  • Niagen Bioscience's Prepaid Assets fell 3.20% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 3.20%. This contributed to the annual value of $2.5 million for FY2024, which is 1.31% up from last year.
  • Niagen Bioscience's Prepaid Assets amounted to $2.0 million in Q3 2025, which was down 5.32% from $2.1 million recorded in Q2 2025.
  • Niagen Bioscience's Prepaid Assets' 5-year high stood at $4.3 million during Q3 2022, with a 5-year trough of $972,000 in Q2 2021.
  • Over the past 3 years, Niagen Bioscience's median Prepaid Assets value was $2.2 million (recorded in 2023), while the average stood at $2.2 million.
  • As far as peak fluctuations go, Niagen Bioscience's Prepaid Assets soared by 141.71% in 2022, and later tumbled by 48.74% in 2023.
  • Over the past 5 years, Niagen Bioscience's Prepaid Assets (Quarterly) stood at $1.9 million in 2021, then surged by 59.60% to $3.0 million in 2022, then fell by 17.43% to $2.5 million in 2023, then climbed by 1.31% to $2.5 million in 2024, then declined by 3.20% to $2.0 million in 2025.
  • Its Prepaid Assets stands at $2.0 million for Q3 2025, versus $2.1 million for Q2 2025 and $2.4 million for Q1 2025.